For current publications please use the following link to search the PubMed web site for recent articles published by the Division of Hematology & Oncology faculty.

www.ncbi.nlm.nih.gov/Pubmed
*Note: this will open a new window. Simply close the window to return here.

SELECTED PUBLICATIONS

M. Atiq, M. M. Safa, R. S. Komrokji, A. R. Jazieh, A. F. Muhleman, Z. A. Nahleh: Chemotherapy Improves Survival in VA Patients with Gall Bladder Cancer. ASCO 2006 Gastrointestinal Cancers Symposium.

S. F. Mekan, M. M. Safa, R. S. Komrokji, Z. A. Nahleh, A. R. Jazieh: Is Hyperglycemia a Prognostic Factor in Pancreatic Cancer? ASCO 2006 Gastrointestinal Cancers Symposium.

M. Atiq, M. M. Safa, R. S. Komrokji, , Z. A. Nahleh, M.S Akbar, A. F. Muhleman, , A. R. Jazieh Do Racial differences predict survival amongst VA patients with Colon Cancer. ASCO 2006 Gastrointestinal Cancers Symposium.

R. S. Komrokji, S. F. Mekan, M. M. Safa, Z. A. Nahleh, J. R. Pancoast, A. F. Muhleman, A. R. Jazieh. Hodgkin's lymphoma among veterans: does race matter? Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings. Vol 24, No 18S (June 20 Supplement), 2006: 17538.

M. H. Al Sayyed, S. F. Maken, M. M. Safa, Z. A. Nahleh, J. Pancoast, A. F. Muhleman, A. R. Jazieh, R. S. Komrokji. Hodgkin's lymphoma in the elderly veterans: we need to do better. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings. Vol 24, No 18S (June 20 Supplement), 2006: 17554.

Z. Nahleh, R. Sirkantiah, R. Komrokji, M. Safa, J. Pancoast, A. Muhleman, A. Jazieh. Male breast cancer (MBC) in the VA population: A gender issue? Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings. Vol 24, No 18S (June 20 Supplement), 2006: 587.

A.R. Jazieh, R. Komrokji, S. Patil, D. Flora, M. Knapp and A. Gupta. A Phase II trial of thalidomide (T), irinotecan (I) and gemcitabine (G) in chemonaive patients with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings. Vol 24, No 18S (June 20 Supplement), 2006: 17068.

M. Atiq, M. M. Safa, R. S. Komrokji, A. R. Jazieh, A. F. Muhleman, Z. A. Nahleh: Chemotherapy Improves Survival in VA Patients with Gall Bladder Cancer. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings. Vol 24, No 18S (June 20 Supplement), 2006: 4132.

S. F. Mekan, M. M. Safa, R. S. Komrokji, Z. A. Nahleh, A. R. Jazieh: Is Hyperglycemia a Prognostic Factor in Pancreatic Cancer? Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings. Vol 24, No 18S (June 20 Supplement), 2006: 14078.

M. M. Safa, M. Atiq, R. S. Komrokji, , Z. A. Nahleh, M.S Akbar, A. F. Muhleman, , A. R. Jazieh Do Racial differences predict survival amongst VA patients with Colon Cancer. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings. Vol 24, No 18S (June 20 Supplement), 2006: 3628.

Sanjay Maraboyina, Rami S Komrokji, Rami Y Haddad, Zeina A Nahleh and Malek M Safa: Racial Disparities in Diffuse Large B Cell Lymphoma: A VA population study. Blood (ASH Annual Meeting Abstracts), Nov 2006; 108: 4614.

Rami S Komrokji, Sanjay Maraboyina, Malek M Safa, Zeina A Nahleh, and Rami Y Haddad: Outcome of Diffuse Large B Cell Lymphoma in the VA Health System: Do We Need to Do Better? Blood (ASH Annual Meeting Abstracts), Nov 2006; 108: 4657.

Rami S Komrokji, Sanjay Maraboyina, Rami Y Haddad, Zeina A Nahleh, and Malek M Safa: Outcome of Diffuse Large B cell Lymphoma in the VA system: The Rituximab Era. Blood (ASH Annual Meeting Abstracts), Nov 2006; 108: 4729.

Rami Y. Haddad and Rami S. Komrokji: Infectious Mononucleosis Presenting with Severe Thrombocytopenia, Positive Anti-Platelets Antibodies, and Peripheral Blood Blasts. Blood (ASH Annual Meeting Abstracts), Nov 2006; 108: 3976.

Camille N Abboud, Alison Walker, Rami S Komrokji, et al: Phase I Study of Cladribine, Cytarabine (Ara?C), Granulocyte Colony Stimulating Factor (G?CSF) (CLAG Regimen) and Simultaneous Escalating Doses of Imatinib Mesylate (Gleevec) in Relapsed/Refractory AML. Blood (ASH Annual Meeting Abstracts), Nov 2006; 108: 1958.

Rami S. Komrokji: "Evolving classifications of the myelodysplastic syndromes" published in Current Hematology Opinion, 2007 Mar; 14(2):98-105.

Saha A, Baral RN, Chatterjee SK, Mohanty K, Pal S, Foon KA, Primus FJ, Krieg AM, Weiner GJ, Bhattacharya-Chatterjee M. CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice. Cancer Immunology Immunotherapy 55(5): 51527, 2006.

Saha A, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen. Immunology 118(4): 483?496, 2006. Erratum in: Immunology 119(1): 143, 2006.

Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. Cancer Research 67(6): 2881?2892, 2007.

Mohanty K, Saha A, Pal S, Mallick P, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M. Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu. Breast Cancer Research and Treatment, in press, 2007.